Vanderbilt-Ingram Cancer Center

Pink will be the color of the day during the Vanderbilt Commodore Women’s Basketball Team Pink Out! event to raise awareness for breast cancer research Sunday, Jan. 29, at 2 p.m. The Commodores will wear pink uniforms in their matchup in Memorial Gymnasium against the LSU Tigers. Fans are also invited to wear pink, the [...]

Endometrial cancer, or cancer of the uterine lining, is the most common gynecological malignancy. Obesity – defined as a body mass index (BMI) of 30 or higher – is a well-established risk factor for endometrial cancer, with obese women having a 4- to 6-times higher risk of the malignancy than nonobese women. Ryan Delahanty, Ph.D., [...]

Vanderbilt-Ingram Cancer Center physician-scientists who created the new online medical decision support tool called “My Cancer Genome” have been named winners of a $20,000 health care technology award sponsored by the National Cancer Institute. The contest, “Using Public Data for Cancer Prevention and Control: From Innovation to Impact Developer Challenge,” was presented as part of [...]

The National Cancer Institute has renewed a $4.4 million, five-year grant to fund training for senior fellows and junior faculty for careers in cancer-oriented research. The goal of the Vanderbilt Clinical Oncology Research Career Development Program is to train clinician scientists who can design and implement clinical oncology trials and lead translational research projects. The [...]

A team of Vanderbilt-Ingram Cancer Center scientists, led by Daniel Liebler, Ph.D., professor of Biochemistry, Biomedical Informatics and Pharmacology, has been selected to participate in the Clinical Proteomic Tumor Analysis Consortium (CPTAC), a multi-center cancer research program created by the National Cancer Institute (NCI). Liebler will lead the Vanderbilt Proteome Characterization Center, one of five [...]

The gold standard for definitive diagnosis of a lung nodule is surgical removal (resection). However, between 10 percent and 30 percent of suspicious nodules are benign. Because thoracic operations are highly invasive and pose significant risks, these operations have been labeled “unnecessary” or “futile.” Eric Grogan, M.D., M.P.H., and colleagues report that, even when surgical [...]

Identifying the molecular pathways that lead normal colon cells to become cancer cell could provide much needed biomarkers and therapeutic targets. Previously, Punita Dhawan, Ph.D., and colleagues showed that claudin-1 – a protein member of “tight junctions” that help bind cells together into an organized tissue structure – was greatly increased and mislocalized in colorectal [...]

The list of aging-associated proteins known to be involved in cancer is growing longer, according to research by investigators at Vanderbilt-Ingram Cancer Center and the National Institutes of Health (NIH). The new study, published Oct. 17 in Cancer Cell, identifies the protein SIRT2 as a tumor suppressor linked to gender-specific tumor development in mice. Along [...]

MyCancerGenome, the online medical decision support tool for cancer care developed by Vanderbilt physician-scientists, has been selected as a finalist for a health care technology award. The contest, “Using Public Data for Cancer Prevention and Control: From Innovation to Impact Developer Challenge,” is sponsored by the National Cancer Institute (NCI), Division of Cancer Control and [...]

Cancer Queens! A Cancer Prevention Musical Revue is a 45-minute, live show featuring skits and song and dance routines set to popular music with new educational lyrics that are consistent with the educational messages of the American Cancer Society, the Centers for Disease Control and Prevention and the National Cancer Institute. Cancer Queens! is a [...]